SG11202009006WA - Polysaccharides for the treatment of ocular conditions - Google Patents

Polysaccharides for the treatment of ocular conditions

Info

Publication number
SG11202009006WA
SG11202009006WA SG11202009006WA SG11202009006WA SG11202009006WA SG 11202009006W A SG11202009006W A SG 11202009006WA SG 11202009006W A SG11202009006W A SG 11202009006WA SG 11202009006W A SG11202009006W A SG 11202009006WA SG 11202009006W A SG11202009006W A SG 11202009006WA
Authority
SG
Singapore
Prior art keywords
polysaccharides
treatment
ocular conditions
ocular
conditions
Prior art date
Application number
SG11202009006WA
Inventor
Jennifer Dourlat
Philippe Daull
Jean-Sébastien Garrigue
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Sas filed Critical Santen Sas
Publication of SG11202009006WA publication Critical patent/SG11202009006WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
SG11202009006WA 2018-03-26 2019-03-26 Polysaccharides for the treatment of ocular conditions SG11202009006WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305332 2018-03-26
PCT/EP2019/057599 WO2019185632A1 (en) 2018-03-26 2019-03-26 Polysaccharides for the treatment of ocular conditions

Publications (1)

Publication Number Publication Date
SG11202009006WA true SG11202009006WA (en) 2020-10-29

Family

ID=61899141

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009006WA SG11202009006WA (en) 2018-03-26 2019-03-26 Polysaccharides for the treatment of ocular conditions

Country Status (10)

Country Link
US (1) US11452739B2 (en)
EP (1) EP3773610A1 (en)
JP (1) JP2021519281A (en)
KR (1) KR20200144096A (en)
CN (1) CN112165948A (en)
CA (1) CA3095244A1 (en)
EA (1) EA202000301A1 (en)
PH (1) PH12020551448A1 (en)
SG (1) SG11202009006WA (en)
WO (1) WO2019185632A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5025045B2 (en) * 2001-02-02 2012-09-12 マルホ株式会社 Enhancement of TIMP production by polysulfated polysaccharides
JP2009057285A (en) * 2005-12-21 2009-03-19 Konan Kako Kk Angiogenesis inhibitor and use thereof
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
ES2390033B1 (en) * 2010-11-30 2013-10-31 Lipotec S.A. EXOPOLISACÁRIDO FOR THE TREATMENT AND / OR CARE OF SKIN, MUCOSAS, HAIR AND / OR NAILS.
FR2981847B1 (en) * 2011-10-28 2013-11-15 Courtage Et De Diffusion Codif Internat Soc D COSMETIC OR PHARMACEUTICAL COMPOSITIONS OF AN EXOPOLYSACCHARIDE FROM A MARINE BACTERIUM
CN104055729A (en) 2013-03-22 2014-09-24 上海现代药物制剂工程研究中心有限公司 Azithromycin eye drops and preparation method thereof
WO2017134352A1 (en) * 2016-02-02 2017-08-10 Engie Method for preventing the formation of bio-fouling on a material in contact with an aqueous medium

Also Published As

Publication number Publication date
US20210106610A1 (en) 2021-04-15
WO2019185632A1 (en) 2019-10-03
JP2021519281A (en) 2021-08-10
KR20200144096A (en) 2020-12-28
EP3773610A1 (en) 2021-02-17
CN112165948A (en) 2021-01-01
EA202000301A1 (en) 2020-12-18
PH12020551448A1 (en) 2021-08-23
US11452739B2 (en) 2022-09-27
CA3095244A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
PL3618829T3 (en) Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
EP3634417C0 (en) Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
GB201804514D0 (en) Treatment of pyroptosis
ZA202007055B (en) Compositions for the treatment of skin conditions
HK1256721A1 (en) Compounds and compositions for the treatment of ocular disorders
ZA202006610B (en) Compositions for the treatment of skin conditions
IL274234B (en) Compositions and methods for the treatment of eye disorders
IL272601A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
GB201804515D0 (en) Treatment of necroptosis
IL270362B (en) Treatment of glaucoma
IL269698B (en) Methods of preventing or treating ophthalmic diseases
EP3813872A4 (en) Compositions for the treatment of skin conditions
GB201907305D0 (en) Treatment of conditions
SG11202009006WA (en) Polysaccharides for the treatment of ocular conditions
EP3658217A4 (en) Treatment of eye disorders
AU2017902737A0 (en) Treatment of ocular conditions
GB201805556D0 (en) Treatment of ophthalmological conditions
GB201917253D0 (en) Treatment of conditions
SG11202007642RA (en) Treatment of disorders with tasimelteon
GB201904764D0 (en) Treatment of ophthalmological conditions
EP3658218A4 (en) Treatment of eye disorders
GB201705435D0 (en) Treatment of ocular disease
AU2017902346A0 (en) Methods of treating ocular disorders